Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

New York sewer rats are easily infected by SARS-CoV-2, according to new study

New York sewer rats are easily infected by SARS-CoV-2, according to new study

Myocarditis after COVID vaccination is rare but higher in younger males

Myocarditis after COVID vaccination is rare but higher in younger males

Novel mRNA vaccines encoding Monkeypox virus proteins show promise in preclinical studies

Novel mRNA vaccines encoding Monkeypox virus proteins show promise in preclinical studies

Plant-based monoclonal antibody increases potency of antibody cocktail against SARS-CoV-2 Omicron variant

Plant-based monoclonal antibody increases potency of antibody cocktail against SARS-CoV-2 Omicron variant

SARS-CoV-2 seroprevalence in domestic cats has increased over time

SARS-CoV-2 seroprevalence in domestic cats has increased over time

Proteomic analysis identifies novel phenotypes associated with COVID-19 severity in circulating immune cells

Proteomic analysis identifies novel phenotypes associated with COVID-19 severity in circulating immune cells

Males exposed to COVID-19 in utero may be at elevated risk of neurodevelopmental disorders

Males exposed to COVID-19 in utero may be at elevated risk of neurodevelopmental disorders

Effects of implemented vaccine rollout strategies on spread of SARS-CoV-2, subsequent global burden of disease, and emergence of novel variants

Effects of implemented vaccine rollout strategies on spread of SARS-CoV-2, subsequent global burden of disease, and emergence of novel variants

Approved and developing passive and active immunizations against respiratory syncytial virus in childhood and pregnancy

Approved and developing passive and active immunizations against respiratory syncytial virus in childhood and pregnancy

US experienced higher COVID-19 mortality during delta and omicron waves

US experienced higher COVID-19 mortality during delta and omicron waves

The biological properties of the SARS-CoV-2 E protein in the context of HIV-1

The biological properties of the SARS-CoV-2 E protein in the context of HIV-1

Potent hypervalent nanoparticles against HIV, Lassa and SARS-CoV-2 variants

Potent hypervalent nanoparticles against HIV, Lassa and SARS-CoV-2 variants

Elevated incidence and risk for a new diagnosis of diabetes after COVID-19

Elevated incidence and risk for a new diagnosis of diabetes after COVID-19

Study finds no benefits from angiotensin receptor blocker treatment for COVID-19

Study finds no benefits from angiotensin receptor blocker treatment for COVID-19

Additional mRNA COVID vaccine doses could salvage antibody responses in blood cancer patients

Additional mRNA COVID vaccine doses could salvage antibody responses in blood cancer patients

New method for isolating Omicron subvariant and evaluating resistance to therapeutic and vaccine-elicited antibodies

New method for isolating Omicron subvariant and evaluating resistance to therapeutic and vaccine-elicited antibodies

Increase in Candida auris infections among EU/EEA nations between 2020 and 2021

Increase in Candida auris infections among EU/EEA nations between 2020 and 2021

What is the association between particulate matter exposure and SARS-CoV-2 infections?

What is the association between particulate matter exposure and SARS-CoV-2 infections?

Chitin-immobilized nanobodies for SARS-CoV-2 detection

Chitin-immobilized nanobodies for SARS-CoV-2 detection

SARS-CoV-2 infection and mRNA vaccination prime transcriptionally distinct CD4+ T cell memory landscapes

SARS-CoV-2 infection and mRNA vaccination prime transcriptionally distinct CD4+ T cell memory landscapes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.